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Biocompatible calcium phosphate ceramic grafts are able of supporting new bone forma-
tion in appropriate environment. The major limitation of these materials usage for medical
implants is the absence of accessible methods for their patient-specific fabrication. 3D
printing methodology is an excellent approach to overcome the limitation supporting
effective and fast fabrication of individual complex bone substitutes. Here, we proposed
a relatively simple route for 3D printing of octacalcium phosphates (OCP) in complexly
shaped structures by the combination of inkjet printing with post-treatment methodology.
The printed OCP blocks were further implanted in the developed cranial bone defect
followed by histological evaluation. The obtained result confirmed the potential of the
developed OCP bone substitutes, which allowed 2.5-time reducing of defect’s diameter
at 6.5months in a region where native bone repair is extremely inefficient.
Keywords: 3D printing, tricalcium phosphate, octacalcium phosphate, ceramics, bone graft, in vivo test, osteo-
conductivity
Introduction
Biocompatible synthetic grafts and/or tissue engineering constructions prevail over conventional
approaches based on autologous, allogenous, or xenogenous bone tissue. However, complex struc-
ture and properties of natural bone limit the spectrum of synthetic materials and fabrication
techniques that could be used as custom-designed implants or scaffolds for bone defects replacement
or guided bone regeneration. Currently, this problem might be solved via a 3D printing technique
(Bergmann et al., 2010; Bose et al., 2013; Popov et al., 2014).
Synthetic calciumphosphates’ (CP) chemical similarity to the natural bonemineral content allows
to apply it successfully as bone substitutes among a variety of other materials (ceramics, bioglasses,
polymers, and their combinations). A number of CP biomaterials with different phase compositions
[hydroxyapatite (HA), tricalcium phosphate (TCP), ion-substituted CP, etc.] and several formula-
tions have been developed over the last few decades (Bohner, 2010; Dorozhkin, 2011). Most of these
biomaterials are used in clinical practice as granules, cements, or porous blocks (Bohner, 2010). TCP
ceramics are a reliable, osteoconductive, and biodegradable material, and it is already commercially
available (Suba et al., 2006; Horowitz et al., 2009; Stavropoulos et al., 2010). However, it has recently
been demonstrated that octacalcium phosphate (OCP) spherical microporous ceramic granules are
three times more effective than TCP for bone marrow mesenchymal stromal cells differentiation
in vivo (Zorin et al., 2014). Additionally, OCP ceramics possess osteogenic features of interest,
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e.g., stimulate lamellar bone formation for 2months after in vivo
implantation. About 4–5months after OCP ceramics implanta-
tion in clinical trials computer tomography (CT) and histological
examinations of patient’ biopsies of the bone defect revealed new
bone formation (Komlev et al., 2014). Thus, OCP-based implants
are the most promising for 3D printing.
There are twomajor techniques currently available for ceramics
3D printing. The first one is mixing of CP powders or agglomer-
ates with polymers, e.g., collagen, followed by their chemical solid-
ification, and finally high-temperature processing (Detsch et al.,
2011; Rath et al., 2012). Another technique comprises sacrificial
inverse matrix printing, its infiltration with ceramic slurry, and
burning out the negative (Guo et al., 2009; Schumacher et al.,
2010).
The main concept of our work is based on an approach, which
involved chemical interaction between initial CP powder, such
as TCP, and binder liquid (“ink”), such as diluted phosphoric
acid, followed by chemical treatment of the printed dicalcium
phosphate dihydrate (DCPD) structures in solutions. Therefore,
a support material burning out was not necessary that prevented
undesirable contamination and risk of OCP decomposition.
Materials and Methods
Chemicals and Reagents
All reagents were purchased from Sigma-Aldrich: high-purity-
grade calcium nitrate (Cat. No: 13477-34-4), ammonium carbon-
ates (Cat. No: 506-87-6), ammonium phosphate monobasic (Cat.
No: 7722-76-1), potassium carbonate-sodium carbonate mixture
(Cat. No: 10424-09-6), and sodium acetate (Cat. No: 127-09-3).
Tricalcium phosphate powder was synthesized in an aque-
ous medium by slow addition of diammonium phosphate
[(NH4)2HPO4] solution into calcium nitrate [Ca(NO3)24H2O]
solution, containing NH4OH, under constant stirring. The pH of
the mixture was about 7 with Ca/P molar ration of 1.5/1. After
total addition of the reactants, the suspension was filtered, dried
at 80°C and sintered at 700°C for 2 h. TCP agglomerateswithmean
size 40–80µmwere used for printing. TCP crystal aggregates were
prepared by light grinding using a pestle and then passing through
a standard testing sieve.
1.0% aqueous solution of salts of phosphoric acid (pH 4.75) was
used as “ink” for the 3D printer. The buffer solution was prepared
by dissolving in water of 1.5 0.1M sodium acetate, 1.0 0.1M
phosphoric acid, and 0.15 0.01M glutamic acid.
Printing Process
To develop the process of layer-by-layer 3D printing of OCP bone
substitutes, we used our custom-designed 3D printer (shown in
Figure 1). Briefly, it consists of a ceramic powder stuffer with
a spreader (3) and Z-piston (4) inside a building box (5), pro-
viding TCP powder layer up and down movement according to
computer-controlled algorithm. Bidirectional (X–Y) positioning
system with a printing head (2) made from modified cartridges
for standard inkjet printer (HP C6602A, Hewlett-Packard, USA).
Both Z-piston and X–Y movement of printing head (“ink” con-
tainer with nozzles producing droplet size ca. 40 pL) are driven
with stepper motors (6) with X–Y–Z accuracy of ca. 40µm.
FIGURE 1 | Custom-designed 3D printer. 1, 3D printer frame; 2, printing
head; 3, stuffer with spreader; 4, Z-piston; 5, building box; 6, stepper motors.
Flexibility of our 3D printer design comprising relatively small
building envelope (60mm 60mm 60mm) permits testing of
small amounts of powder materials. It makes possible fast and
inexpensive study of both new process techniques and new mate-
rial combinations.
Initially, a 3D dataset of desired ceramic model (a bulging disk
with a diameter 20mm and 16 perforations of 1mm in diame-
ter) in the STL format is uploaded to the system. The recoating
mechanism (3) carries an amount of fine (40–80µm)TCP powder
to the building box, creating a thin (ca./200µm) layer of powder
on the top of the Z-piston plane (4) inside the building box (5)
at room temperature. The liquid binder (200 pL/point) is ejected
from the printing head onto the powder layer with linear speed
up to 10mm/s, wetting individual cross-section. When the layer
is completed, Z-piston moves down by the thickness of a layer
(ca./200µm) and a new layer of powder is deposited on the printed
one. These process steps are repeated until the whole sample is
formed within the powder bed. The surrounding powder material
supports the ceramic model during the printing process. Thus,
there is no necessity for further maintenance structures for such
features as overhangs and undercuts. Upon completion, the sam-
ple is removed from the building box, cleaned using an air blower,
and air dried at room temperature for further chemical treatment.
Post-Treatment of Printed Structures
After printing, the sampleswere placed in aqueous solution, which
was prepared by dissolving of 115 g of NH4H2PO4 in 500mL
of distilled water at room temperature. The pH of the solution
was 4.1 0.1. The samples were kept for 168 h at 40°C. After
incubation, the samples were thoroughly washed in distilled water
at least 10 times, dried at 37°C and placed in a second solution,
whichwas prepared by dissolving 95.2 g of CH3COONa in 700mL
of distilledwater at 40°C and pH8.2 0.2. The samples were again
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kept for 168 h at 40°C, thoroughly washed in distilled water at least
five times and dried overnight at 37°C (Komlev et al., 2014).
Material Characterization
Phase composition was analyzed by conventional X-ray diffrac-
tion (XRD) technique [Shimadzu XRD-6000 (Japan), Ni-filtered
CuKα1 target, λ= 1.54183Å]. The samples were scanned from
2θ= 3°–60° with a 0.02° step a preset time of 5 s.
Scanning electron microscopy (SEM) apparatus (Tescan Vega
II, Czech Republic), working in secondary and backscattered elec-
tron modes, was used for microstructure studies. The samples
were sputter-coated with a 25 nm-thick gold layer prior imaging
to impart electrical conductivity to the surfaces.
The compressive strength of samples was evaluated in accor-
dance with the ISO standard 9917E. The 3D printed cylindrical
samples were about 12mm in height and 6mm in diameter. Five
samples for each pointwere used. Compression testingwas carried
out using an Instron 4082 (Bucks, UK) testing machine operating
at a crosshead speed of 1mmmin 1. Statistical analysis was
performed using SPSS software, version 17.0 (Statistical Pack-
age for Social Sciences, SPSS Inc., USA). The means and SD of
compressive strength were calculated.
In vivo Test: Cranial Model
All manipulations with rabbits (n= 5) were carried out in accor-
dance with Animal Welfare Act in the vivarium of the A.I. Bur-
nazyan Federal Medical Biophysical Center. The experimental
study protocol was approved by theMoscow Interuniversity Ethics
Committee (protocol No. 12–13 from December 12, 2013).
Implantation of the 3D Printed Bone Graft
The animals underwent intramuscular premedication (Sol.
Atropini sulfatis 0.1% – 0.04mg/kg; Sol. Cefazolini 1.0 –
25mg/kg) and sedation (Sol. Zoletili 100 – 15mg/kg) before
positioning on the operating table special for rabbits and fixation:
lying on an abdomen with the paws extended and attached. A
linear 3 cm skin incision was performed to a periosteum over
sagittal suture from occipital protuberance to the frontal area
under local anesthesia (Sol. Ultracaini 1.7mL). Local anesthetic
was applied into the skin and underlying tissues infiltrating
periosteum. Soft tissues were lateralized, and the cranial bones
surface was exposed. Previously prepared sterile template (disk
20mm in diameter) was positioned in the center of calvaria
from occipital to frontal bone and was used for marking of the
defect edges. After that, a template was removed, and osteotomy
was made with a bur to form the full-thickness defect (diameter
20mm) keeping a dura mater uninjured and preserving the small
fragments of inner cortical bone (1mm 1mm) in the 1, 5, 7, and
11 o’clock positions as the points of support. Bleeding from the
damaged sagittal sinus was stopped by coagulation. 3D printed
block exactly corresponding to the defect form was implanted on
the retained cortical bone fragments. Surgical wound was closed
on multiple tissue levels with interrupted sutures (MonoSyn 4/0).
No pain management was required postoperatively. The rabbits
were deceased at 6.5months after surgery. Each calvaria with the
bone defect region was removed, fixed in 4% neutral formalin,
and subjected to further studies.
Computer Tomography
Explanted material underwent a CT after 3 days of fixation. Scan-
ning parameters were as follows: voxel size 8µm, 80 kV, and
2mA.
The tomograms were analyzed with Planmeca Romexis viewer
(Planmeca Oy, Finland). Additionally, we carried out a manual
segmentation of the area with implanted 3D printed samples and
calculated a density (HU) of selected zone in a standard module
of 3D-Slicer (NHI, USA).
Histological Examination
Histological slices weremade according to the standard procedure
after decalcification of the explanted calvaria in the “Biodek-R”
solution (Bio-Optica, Italy). All sections were made strictly in the
frontal plane through the center of the implant with preservation
of parietal bones fragments attached to each side of the 3D printed
block (length of the sample was about 25mm). Histological
sections were stained with hematoxylin and eosin and subjected
to scanning (Mirax scanner, Carl Zeiss, Germany). Digital images
of the histotopograms were analyzed at various magnifications.
Results and Discussion
3D printing technique based on cement powders is an effective
and inexpensive method for individual and complex bone substi-
tute’s fabrication since there is neither support materials burning
out nor organic solvent required (Castilho et al., 2014). Setting and
hardening processes during 3D printing are based on two types of
interaction, which depend on the raw materials used. The first is
an acid–base reaction with the formation of a neutral compound.
The second one is the hydrolysis reaction of the metastable CP.
Both resulted in an adhesive effect between the particles. The
final phases of the cement product are apatite or DCPD (Khalyfa
et al., 2007; Gbureck et al., 2008; Klammert et al., 2010). An
approach was reported utilizing further cement matrix formation
consisting of a mixture of HA/TCP by following heat treatment
(Castilho et al., 2014). CP materials printed with these techniques
are biocompatible and possess certain osteoconductive properties.
Our work is a combination and further development of the pro-
cesses involving chemical interaction between initial CP powder,
such as TCP and binder liquid (“ink”) such as diluted phosphoric
acid (Popov et al., 2014), followed by chemical treatment of the
printed DCPD structure with chemical solutions at physiological
temperatures. It is known that TCP upon treatment with phos-
phoric can be used as bone cement forming DCPD, which further
can be transformed into OCP (Heughebaert et al., 1983). The 3D
printing process of TCP powders with phosphoric acid is based
on a hydraulic setting reaction leading to DCPD crystallization,
and thus to layer-crossing bonding of the powder finally resulting
in the formation of a 3D structure. The printed samples consist
of unreacted TCP and certain amounts of DCPD (Figure 2A).
SEM photomicrographs of both TCP and DCPD phases are pre-
sented in Figures 2B1,B2. Size of the unreacted TCP particles
was 5–15µm (Figure 2B1). The DCPD crystals had a flower-like
morphology. The width of the DCPD crystals was in range from
1 to 50µm, and their thickness ranged from a fraction of few
microns (Figure 2B2). Compressive strength of the 3D printed
samples is shown in Figure 3 and was only about 2.5MPa.
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A B3
B2
B1
FIGURE 2 | (A) XRD chart of the transformation of 3D printed TCP (1) to DCPD
samples soaked in calcium nitrate solution during 168 h (2) and to OCP samples
in sodium acetate during 168 h (3). SEM photomicrographs of 3D printed
samples: (B1) TCP (pre-treated material), (B2) DCPD (after soaking in calcium
nitrate solution at 168 h), and (B3) OCP (after soaking in sodium acetate at
168 h).
FIGURE 3 | Compressive strength of 3D printed samples before and
after chemical treatment.
To this end, the chemical and phase composition of the 3D
printed samples is to be fixed by completing acid–base reaction
with DCPD compound formation. Further hydrolysis reaction of
the metastable CP results in the formation of OCP phase and an
adhesive effect between particles. This process is represented in
Figure 2A, where the transformation from TCP to DCPD was
completed after 168 h of soaking in the solution. The obtained
3D printed samples with DCPD phase composition were trans-
formed into OCP of soaking in sodium acetate, according to XRD
(Figure 2A). XRDof theOCP samples devoted predominantOCP
phase with (100) reflection at 2θ= 4.9°. However, the modified
samples contained small amounts of unreacted DCPD, as well
as new nucleated HA phase (after 168 h of soaking in sodium
acetate). High intensity of diffraction peaks indicate high crys-
tallinity of OCP materials (Figure 2A). OCP plates were needle-
like 2–5µm long and 1–2µm wide (Figure 2B3).
From the data that were presented in Figure 2, the following
mechanism can be established: in the initial stage, the pH was
low due to the presence of phosphoric acid, and the reaction
between Ca3(PO4)2 and H3O+ yielded Ca2+ ions. The Ca2+ ions
reacted with HPO2 4 ions, which formed CaHPO42H2O. The
further increase of the values of pH of the solution during the
post-treatment leads to OCP nucleation and growth.
Compressive strength of 3D printed samples and post treated
structures is shown in Figure 3. The compressive strength of
the post treated material increased with time from 2.5MPa up
to about 7.5MPa at P 0.005. The increase in the compressive
strength after treatment can be explained by the formation of
new OCP crystals within 3D printed samples, which improve the
bonding between particles. These OCP samples were used for
in vivo experiments.
An adequate in vivo model for objective evaluation of qualita-
tive and quantitative parameters of substitute’s biological action is
utterly important for successful development of 3D printed bone
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grafts. There are numerous orthotropic animal models: various
defects of long bones, mandible, parietal, and frontal bones. How-
ever, the majority of bone defects in these models is not large
enough or require complex fixation. By choosing an appropriate
model for our study, we considered the following criteria: bone
defect should be the “maximum-sized” but should not require
additional methods of fixation, e.g., osteosynthesis with mini-
plates, screws, etc., affecting bone regeneration process and, in
general, the study results. For this purpose, we developed the
original experimentalmodel of a cranial bone defect characterized
by large diameter (20mm) and preservation of four fragments of
inner cortical bone in special positions (1, 5, 7, and 11 o’clock)
as points for implant support. This model allowed 3D printed
block to be optimally immobilized into the bone defects without
additional fixation methods (Figures 4A,B).
Postoperatively, there were no signs of acute inflammation,
edema, and other adverse events; wound healed by primary inten-
tion. According to CT, the peripheral sides of implanted material
were fully integrated with surrounding bone tissue (Figure 4).
Moreover, there were sites of newly formed tissue, apparently
A
B
C D
FIGURE 4 | (A) General view of 3D printed samples to be implanted. (B) Photomicrograph of the cranial defect produced. (C) 2D slices in different areas. (D) 3D CT
reconstruction for 3D printed block at 6.5months after implantation.
A
B C D E
FIGURE 5 | Histological slides of the rabbit’s calvaria bones, slice
made in the coronal plane: (A) Histotopogram, including two
regions of newly formed bone tissue growing toward each other;
(B) the central area, where a fragment of the woven bone tissue
formed on the implant surface without fibrous tissue interlayer; (C)
the central area with pore in the 3D printed implant a fibrous tissue
with single vascular vessels grow out through (*); (D) a fragment of
the marginal part of the regenerate where newly formed bone
tissue grew directly on the 3D printed block surface; (E) the
marginal part of the regenerate having pronounced newly formed
bone trabecule retaining the implant. 1, 3D printed block made of
octacalcium phosphate; 2, newly formed bone tissue; *vascular vessel.
Staining: hematoxylin and eosin, paraffin sections. Magnification: (A) 4,
(C–E) 100, (B) 200.
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consisting of bone (767.56 145.81 HU), grown centripetally
from the temporal edges and tightly adjacent to the inner and
external surfaces of the 3D printed block as though enfolding its
peripheral parts. A bone regenerate proceeded fromoccipital bone
had the most length that was defined, apparently, by its greater
thickness. The average density of thematerial was 1851.29 58.26
HU 6.5months after implantation that impeded evaluation of tis-
sue ingrowths into the 3D printed sample. Indirectly, the presence
of gaps and sites of superposed edges of the material fragments in
the block could identify this process. However, the fragmentation
could be related to a mechanical impact of a rabbit’s activity.
Histological study revealed that 3D printed block was biocom-
patible: in spite of the large dimensions and the absence of a firm
fixation to surrounding structures, material directly contacted
with newly formed bone without fibrous encapsulation or even
slight connective tissue areasmaking them apart (Figure 5). In the
central part of the defect, no signs of osteogenesis were observed;
material here was surrounded by fibrous tissue grown into the
block’s pores.
A cross-section shows that a “material–bone tissue” interaction
could occur by twoways. First, the bone tissue grows over external
and under internal surfaces of the OCP block, but does not pene-
trate it as the structure was not porous that preserved mechanical
qualities of the material. Second, regenerating calvarial bones can
grow under the block using it as a conductor. The second way is
probably associated with surgical implantation technique.
General feature of this 3D printed block is blood vessels, cells
of granulation tissue, as well as osteogenic cells permeability. Bone
formation occurred in the sites of close contact with the material
that could also be found in the central part of the defect, without
any apparent connection with regenerate grown from the edges.
In crack sites, the material fragments injured regenerating tissues
that led to local giant cell reaction. This finding together with
abovementioned confirmed that the gaps were caused by animal
activity rather than tissues ingrowths.
The printed implants supported bone regeneration that allowed
2.5-time reducing of defect’s diameter at 6.5months in a region
where native bone repair is extremely inefficient.
Conclusion
The results of our study demonstrate that combination of 3D
inkjet printing with post-treatment methodology is a promising
approach to overcome current limitations in effective and fast fab-
rication of individual constructions for guided bone regeneration.
We proposed and developed a relatively simple route and materi-
als for 3D printing process, targeted to production of complexly
shaped and structured OCP bone substitutes. We showed experi-
mentally that 3D inkjet powder printing is a suitable technique for
custom-designed critical size OCP bone grafts production.
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